Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” fourth quarter 2024 investor ...

Analysts fell to the sidelines weighing in on Equifax (EFX – Research Report) and Trane Technologies (TT – Research Report) with neutral ...

Equifax (NYSE:EFX – Free Report) had its price objective decreased by Jefferies Financial Group from $340.00 to $300.00 in a ...

The Consumer Financial Protection Bureau (CFPB) has fined Equifax Inc. $15 million for failing to properly investigate ...

Akero Therapeutics (AKRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce from ...

H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing ...

Equifax management has steered the company through a lengthy and onerous transition. Learn why EFX stock is a Buy.

Short EFX slightly under 248.28, target n/a, stop loss @ 249 Check the time stamp on this data. Updated AI-Generated Signals for Equifax Inc. (EFX) available here: EFX. Type a few symbols and Take a ...

Below is Validea's guru fundamental report for EQUIFAX INC (EFX). Of the 22 guru strategies we follow, EFX rates highest using our P/B Growth Investor model based on the published strategy of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...